Veritas Pharma Inc. Reports Earnings Results for the Third Quarter Ended January 31, 2020
Veritas Pharma Inc. announced earnings results for the third quarter ended January 31, 2020. For the third quarter, the company announced net loss was CAD 256,074 compared to CAD 853,206 a year ago. Basic loss per share was CAD 0.02 compared to CAD 0.09 a year ago. For the nine months, net loss was CAD 1.409 million compared to CAD 3.851 million a year ago. Basic loss per share was CAD 0.12 compared to CAD 0.48 a year ago.